Reduced susceptibility to EAE in CD26 (dipeptidyl-peptidase IV) deficient F344 rats

被引：0
|
作者：
von Hörsten, S [1 ]
Theil, MM [1 ]
Schween, J [1 ]
Bedoui, S [1 ]
Wedekind, D [1 ]
Pabst, R [1 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 154卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
235
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl-peptidase IV-β -: Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26
    Blanco, J
    Nguyen, C
    Callebaut, C
    Jacotot, E
    Krust, B
    Mazaleyrat, JP
    Wakselman, M
    Hovanessian, AG
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 256 (02): : 369 - 378
  • [2] DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26) AND INFLAMMATORY BOWEL DISEASE
    Pucar, Lara Baticic
    Detel, Dijana
    Varljen, Jadranka
    ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2012, 63 (01): : 75 - 100
  • [3] Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
    Mentlein, R
    REGULATORY PEPTIDES, 1999, 85 (01) : 9 - 24
  • [4] Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity
    Karl, T
    Hoffmann, T
    Pabst, R
    von Hörsten, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 75 (04) : 869 - 879
  • [5] CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes
    van Lingen, R. G.
    de Kerkhof, P. C. M. van
    Seyger, M. M. B.
    de Jong, E. M. G. J.
    van Rens, D. W. A.
    Poll, M. K. P.
    Zeeuwen, P. L. J. M.
    van Erp, P. E. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (06) : 1264 - 1272
  • [6] CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity
    Guieu, R
    Fenouillet, E
    Devaux, C
    Fajloun, Z
    Carrega, L
    Sabatier, JM
    Sauze, N
    Marguet, D
    BEHAVIOURAL BRAIN RESEARCH, 2006, 166 (02) : 230 - 235
  • [7] Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach
    Garcia-Aparicio, Carlos
    Bonache, Maria-Cruz
    De Meester, Ingrid
    San-Felix, Ana
    Balzarini, Jan
    Camarasa, Maria-Jose
    Velazquez, Sonsoles
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (17) : 5339 - 5351
  • [8] Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases
    Novelli, M
    Savoia, P
    Fierro, MT
    Verrone, A
    Quaglino, P
    Bernengo, MG
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (06) : 1052 - 1056
  • [9] The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors
    Augustyns, K
    Bal, G
    Thonus, G
    Belyaev, A
    Zhang, XM
    Bollaert, W
    Lambeir, AM
    Durinx, C
    Goossens, F
    Haemers, A
    CURRENT MEDICINAL CHEMISTRY, 1999, 6 (04) : 311 - 327
  • [10] CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model
    Kruschinski, C
    Skripuletz, T
    Bedoui, S
    Tschernig, T
    Pabst, R
    Nassenstein, C
    Braun, A
    von Hörsten, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (01): : 17 - 24
12345